Mira Itani

ORCID: 0000-0003-1703-6811
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Gastric Cancer Management and Outcomes
  • Disaster Response and Management
  • Economic and Financial Impacts of Cancer
  • Renal cell carcinoma treatment
  • Global Cancer Incidence and Screening
  • Renal and Vascular Pathologies
  • COVID-19 and healthcare impacts
  • Viral Infections and Outbreaks Research
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Diagnosis and Treatment
  • Chronic Kidney Disease and Diabetes
  • Metastasis and carcinoma case studies
  • Health and Conflict Studies
  • Breast Cancer Treatment Studies
  • Genetic factors in colorectal cancer
  • Cancer Genomics and Diagnostics
  • Multiple and Secondary Primary Cancers
  • Healthcare cost, quality, practices
  • HER2/EGFR in Cancer Research
  • Organ Donation and Transplantation
  • Radiomics and Machine Learning in Medical Imaging
  • Migration, Health and Trauma
  • Medication Adherence and Compliance
  • Cancer survivorship and care
  • Advanced Breast Cancer Therapies

Cleveland Clinic Florida
2022-2025

American University of Beirut
2015-2024

Emory Healthcare
2024

Cleveland Clinic
2023

Ross School
2023

Retina Consultants of Houston
2023

American University of Beirut Medical Center
2021

Abstract Background Older adults are more prone to increasing comorbidities and polypharmacy. Polypharmacy is associated with inappropriate prescribing an increased risk of adverse effects. This study examined the effect polypharmacy in older on healthcare services utilization (HSU). It also explored impact different drug classes including psychotropic, antihypertensive, antidiabetic HSU. Methods a retrospective cohort study. Community-dwelling aged ≥ 65 years were selected from primary care...

10.1186/s12875-023-02070-0 article EN cc-by BMC Primary Care 2023-05-26

Among patients with metastatic colorectal cancer (mCRC), data are limited on disparate biomarker testing and its association clinical outcomes a national scale.

10.1001/jamanetworkopen.2024.19142 article EN cc-by-nc-nd JAMA Network Open 2024-07-05

Abstract No consensus exists on the optimal therapy for resectable gastric cancer (GC) and gastroesophageal junction (GEJ) tumors, including effectiveness of chemoradiotherapy versus perioperative chemotherapy (PC). Our study aimed to compare overall survival (OS) outcomes associated with recommended treatment modalities GC GEJ tumors evaluate trends from 2010 2020. A national registry cohort identified patients ≥ cT2 nonmetastatic cancer. Treatment were classified as neoadjuvant (NC),...

10.1038/s41598-024-82807-8 article EN cc-by Scientific Reports 2025-01-22

Background: The COVID-19 pandemic strained healthcare systems around the world. This study aims to understand preparedness of private remote hospitals in Lebanon respond and evaluate impact inter-hospital collaborations on hospitals’ readiness. Methods: A multi-centered was conducted between August 2020 June 2021 ten Lebanese based a mixed-methods embedded approach where quantitative supported qualitative. Through AUB-USAID (American University Beirut-United States Agency for International...

10.3390/healthcare12030321 article EN Healthcare 2024-01-26

Abstract Purpose Disparities in cancer care have been exacerbated by the COVID-19 pandemic. The aim of this study is to establish how telehealth mitigated effect on healthcare sector and identify potential disparities perception experience with during after Methods We identified individuals an established diagnosis who received treatment at a comprehensive academic center diverse patient population between 2019 2021, Participants were asked complete self-administrated survey intended collect...

10.1007/s00520-024-08433-2 article EN cc-by Supportive Care in Cancer 2024-03-20

Thymoma is a rare type of malignancy but considered one the most common neoplasms that occur in anterior mediastinum. A large proportion thymomas are associated with paraneoplastic syndromes, such as myasthenia gravis. Whenever feasible, standard care for treatment thymoma should focus on control surgical resection, and adjuvant therapy if appropriate. 36-year-old female patient significant past medical history obesity iron deficiency anemia who underwent en bloc resection three months prior...

10.7759/cureus.34828 article EN Cureus 2023-02-10

(1) Background: Disparities in cancer treatment and outcomes have long been well-documented the medical literature. With eruption of advances new modalities, long-existing disparities are now being further uncovered brought to attention community. While social health determinants previously linked lung cancer, we analyzed data from National Cancer Database explore sociodemographic geographic factors related accepting or declining physician-recommended chemotherapy. Patients diagnosed with...

10.3390/cancers15061686 article EN Cancers 2023-03-09

The 21-gene recurrence score assay has been validated as a predictive biomarker in early-stage HR+ and HER2-breast cancer. It is not indicated for use HER2+ disease based on national guidelines. In this study, we assessed the value of (RS), or OncotypeDX (ODX), testing HR+/HER2+ breast We used National Cancer Database to identify patients with stages I-II, cancer who received multi-gene ODX. then explored prognostic through various forms survival modeling. ODX was performed n = 5,280...

10.1016/j.breast.2022.09.002 article EN The Breast 2022-09-06

The study aimed to construct and validate a risk prediction model for incidence of postoperative renal failure (PORF) following radical nephrectomy nephroureterectomy.The American College Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database years 2005-2014 were used the derivation cohort. A stepwise multivariate logistic regression analysis was conducted, final validated with an independent cohort from ACS-NSQIP 2015-2017.In 14,519 patients, 296 (2.0%) developed PORF....

10.1159/000519480 article EN Urologia Internationalis 2021-11-19

Abstract Background: OncotypeDX (ODX) is a 21-gene recurrence score (RS) assay that predictive of the benefit adjuvant chemotherapy in early-stage hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer. MammaPrint (MP) 70-gene signature validated to prognosticate distant metastasis survival. We have previously presented data suggesting presence circulating tumor cells (CTCs) evaluated via liquid biopsy may also prognostic utility HR+/HER2- In this study, we compare value ODX,...

10.1158/1538-7445.sabcs22-p6-01-43 article EN Cancer Research 2023-03-01

Abstract Background: Palliative care is an essential component of cancer care; however, factors hindering its reach to the target population remain understudied. We aim explore whether association exists between socioeconomic and geographic access palliative (PC) in patients with Stage IV breast US. Methods: This 2004-2017 National Cancer Database analysis includes who received care. Access PC defined as being either at patient’s primary healthcare facility or a referral site. Chi-square...

10.1158/1538-7445.am2023-746 article EN Cancer Research 2023-04-04

8558 Background: The presence of micro-residual (R1) or macro-residual (R2) disease in non-small cell lung cancer (NSCLC) is associated with a higher risk recurrence. benefits post-operative radiation therapy (PORT) incompletely resected NSCLC not clear. purpose this study to compare median overall survival (mOS) treatment modalities the setting for stage I-IIIA residual (R1/R2) and determine if PORT provides benefit patient population using National Cancer Database (NCDB). Methods: From...

10.1200/jco.2023.41.16_suppl.8558 article EN Journal of Clinical Oncology 2023-06-01

e16097 Background: Surgical resection is established as the only potentially curative approach for patients with early stage and regional gastric cancer. With a high risk of recurrence that ranges between 40% to 60% II III disease, combination therapies including chemotherapy radiation complement surgery were incorporated standard care Stage >IB disease clear survival benefit over alone. While National Comprehensive Cancer Network (NCCN) guidelines recommend neoadjuvant chemoradiation...

10.1200/jco.2023.41.16_suppl.e16097 article EN Journal of Clinical Oncology 2023-06-01

e16102 Background: Patients with cervical esophageal tumors are associated poor survival outcomes a 5-year overall (OS) of 30%. While surgical resection is necessary component trimodality therapy for thoracic and abdominal management, the role surgery unclear upper-third due to high morbidity mortality resulting from proximity anatomical structures in region. Higher chances postoperative complications subsequent functional deficits reported neurovascular organ compromise. Definitive...

10.1200/jco.2023.41.16_suppl.e16102 article EN Journal of Clinical Oncology 2023-06-01

e13674 Background: Disparities in cancer care have been exacerbated by the COVID-19 pandemic. Understanding challenges encountered patients can help alleviate burden of and improve access to care. Methods: We recruited consecutive with at a comprehensive academic center analyzed patient reported socioeconomic mental health challenges, their perception since start pandemic using modified version You Matter: Mental Health Impact Survey. The survey instrument was self-administered once from...

10.1200/jco.2023.41.16_suppl.e13674 article EN Journal of Clinical Oncology 2023-06-01

e20560 Background: The standard of care (SOC) for treatment unresectable, stage III non-small cell lung carcinoma (NSCLC) utilizes both chemotherapy and radiation therapy. Historically, concurrent chemo-radiation therapy (CCRT) has been associated with improved survival outcomes compared to sequential (SCRT). Using data extracted from the National Cancer Database (NCDB). Our primary objective was assess if a particular race cohort received less than any impact on in NSCLC. Methods: From...

10.1200/jco.2023.41.16_suppl.e20560 article EN Journal of Clinical Oncology 2023-06-01

Abstract Introduction All patients with newly diagnosed colorectal cancer are recommended to undergo microsatellite instability (MSI) testing. In addition, mutational testing using biomarkers such as KRAS, NRAS, and BRAF is for metastatic cancers. Testing these markers vital they guide therapeutic decision-making serve prognostic indicators. Our study aims analyze disparities in MSI KRAS based on sociodemographic factors cancer. Furthermore, we explored the survival characteristics access...

10.1158/1538-7445.am2023-5550 article EN Cancer Research 2023-04-04

You have accessJournal of UrologyKidney Cancer: Epidemiology & Evaluation/Staging/Surveillance III (MP61)1 Sep 2021MP61-18 RISK OF POST-OPERATIVE RENAL FAILURE IN RADICAL NEPHRECTOMY AND NEPHROURETERECTOMY: A NOVEL VALIDATED 9-FACTOR RISK-PREDICTION MODEL Ali Nasrallah, Charbel Gharios, Mira Itani, Dania Bacha Beirut, Lebanon, Robert Habib, and Albert El Hajj NasrallahAli Nasrallah More articles by this author , GhariosCharbel Gharios ItaniMira Itani LebanonDania Lebanon HabibRobert Habib...

10.1097/ju.0000000000002101.18 article EN The Journal of Urology 2021-08-04
Coming Soon ...